S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Ipsen Stock Forecast, Price & News

+0.53 (+2.52 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $21.53
50-Day Range
MA: $21.15
52-Week Range
Now: $21.53
Volume121 shs
Average Volume3,996 shs
Market Capitalization$7.22 billion
P/E Ratio11.39
Dividend YieldN/A
Ipsen S.A. operates as a biopharmaceutical company worldwide. It operates in two segments, Specialty Care and Consumer Healthcare. The company offers drugs in the areas of oncology, neuroscience, pituitary pathologies and growth disorders, gastrointestinal disorders, neurodegenerative pathologies, and rheumatology. Its products include Somatuline for neuroendocrine tumors and acromegaly; Cabometyx to treat renal cell and second-line hepatocellular carcinoma; Onivyde for metastatic pancreatic cancer; Decapeptyl to treat advanced metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, female sterility, and early stage breast cancer; and Dysport for motor muscular disorders and medical aesthetics. The company also provides NutropinAq to treat growth failure in children due to growth hormone deficiency, turner syndrome, or chronic renal failure, as well as GH deficiency in adults; and Increlex for long-term treatment of growth failure in children and adolescents. In addition, it offers Smecta for the treatment of chronic and acute diarrhea, and pain linked to oesogastroduodenal conditions and colic; Forlax for constipation; and Fortrans/Eziclen for intestinal cleaning; Etiasa for inflammatory bowel diseases; and Tanakan to treat mild cognitive impairment related to age, pathophysiological deficiencies, vertigo, retinal deficits, acute or chronic hearing impairment, and tinnitus. Further, the company provides Adenuric for chronic hyperuricaemia; Prontalgine, an analgesic to treat moderate to severe pain; Buscopan, an antispasmodic; Suppositoria Glycerini, a laxative; and Mucothiol and Mucodyne, which are expectorants for cough and flu. The company has collaboration agreements with Arix Bioscience plc; The University of Texas MD Anderson Cancer Center; and Exelixis and Roche. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.
Ipsen logo


Overall MarketRank

0.84 out of 5 stars

Medical Sector

1037th out of 1,558 stocks

Diagnostic Substances Industry

20th out of 28 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Diagnostic substances



Sales & Book Value

Annual Sales$3.02 billion
Cash Flow$2.46 per share
Book Value$5.86 per share



Market Cap$7.22 billion
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
+0.53 (+2.52 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IPSEY News and Ratings via Email

Sign-up to receive the latest news and ratings for IPSEY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Ipsen (OTCMKTS:IPSEY) Frequently Asked Questions

How has Ipsen's stock price been impacted by COVID-19?

Ipsen's stock was trading at $14.4150 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IPSEY stock has increased by 49.4% and is now trading at $21.53.
View which stocks have been most impacted by COVID-19

Is Ipsen a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ipsen in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Ipsen stock.
View analyst ratings for Ipsen
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Ipsen?

Wall Street analysts have given Ipsen a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ipsen wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Ipsen's next earnings date?

Ipsen is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Ipsen

Are investors shorting Ipsen?

Ipsen saw a decline in short interest in December. As of December 31st, there was short interest totaling 1,400 shares, a decline of 44.0% from the December 15th total of 2,500 shares. Based on an average trading volume of 1,700 shares, the days-to-cover ratio is currently 0.8 days.
View Ipsen's Short Interest

Who are some of Ipsen's key competitors?

Who are Ipsen's key executives?

Ipsen's management team includes the following people:
  • Mr. David Loew, CEO & Director (Age 53)
  • Mr. Aymeric Le Chatelier, Exec. VP & Group CFO (Age 51)
  • Dr. Aidan Murphy, Exec. VP of Technical Operations (Age 54)
  • Ms. Eugenia Litz, VP of Investor Relations
  • Mr. Francois Garnier, Exec. VP & Gen. Counsel (Age 58)
  • Mr. Christian Marcoux, Sr. Vice-Pres of Global Communications
  • Mr. Regis Mulot, Exec. VP & Chief HR Officer (Age 54)
  • Mr. Stephan Gagne, Head of New Tokyo Office
  • Ms. Dominique Laymand, Exec. VP of Ethics & Social Responsibility Officer (Age 66)
  • Mr. Benoit Hennion, Exec. VP of Consumer Healthcare (Age 44)

What is Ipsen's stock symbol?

Ipsen trades on the OTCMKTS under the ticker symbol "IPSEY."

How do I buy shares of Ipsen?

Shares of IPSEY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ipsen's stock price today?

One share of IPSEY stock can currently be purchased for approximately $21.53.

How big of a company is Ipsen?

Ipsen has a market capitalization of $7.22 billion and generates $3.02 billion in revenue each year. The company earns $-56,780,000.00 in net income (profit) each year or $1.89 on an earnings per share basis. Ipsen employs 5,800 workers across the globe.

What is Ipsen's official website?

The official website for Ipsen is www.ipsen.com.

How can I contact Ipsen?

Ipsen's mailing address is 65 quai Georges Gorse, Boulogne-Billancourt cedex I0, 92650. The company can be reached via phone at 33-01-58-33-50-00 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.